Bristol-Myers Squibb Co. (NYSE: BMY) reported Q2 EPS of $0.48, $0.01 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $4.44 billion versus the consensus estimate of $4.44 billion.

For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.

Earnings